Skip to main content
Sharon Giordano, MD, Oncology, Houston, TX, University of Texas M.D. Anderson Cancer Center

SharonM.GiordanoMD

Oncology Houston, TX

Physician

Are you Dr. Giordano?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 91 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Sharon Giordano, MD is an oncologist in Houston, Texas. She is currently licensed to practice medicine in Texas, Louisiana, and Alabama. She is affiliated with University of Texas M.D. Anderson Cancer Center.

Education & Training

  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1999 - 2002
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 1996 - 1999
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1996

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • WA State Medical License
    WA State Medical License 2023 - 2026
  • OK State Medical License
    OK State Medical License 2020 - 2025
  • TN State Medical License
    TN State Medical License 2023 - 2025
  • GA State Medical License
    GA State Medical License 2023 - 2025
  • AZ State Medical License
    AZ State Medical License 2023 - 2025
  • TX State Medical License
    TX State Medical License 1999 - 2024
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Breast Cancer Survivors Can Safely Interrupt Therapy During Pregnancy: Study
    Breast Cancer Survivors Can Safely Interrupt Therapy During Pregnancy: StudyMay 4th, 2023
  • Breast Cancer Survival Rates Have Steadily Improved for Women—but Not for Men
    Breast Cancer Survival Rates Have Steadily Improved for Women—but Not for MenFebruary 1st, 2023
  • Rachel Freedman, MD, on ASCO's New Guideline for Adjuvant Chemo with Targeted Tx
    Rachel Freedman, MD, on ASCO's New Guideline for Adjuvant Chemo with Targeted TxJuly 19th, 2022
  • Join now to see all

Hospital Affiliations